Article
09 Sep 2024
PTAB Institutes Sarepta's IPR
AUTHORS CONTENT
Article
02 Jul 2024
Biogen's TOFIDENCE (Tocilizumab) Approved In The EU
Article
05 Jun 2024
USPTO Proposed Rulemaking Regarding Terminal Disclaimers
Article
24 Apr 2024
Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation
Article
21 Mar 2024
Celltrion Submits BLA For Omalizumab Biosimilar
Article
16 Jan 2024
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
Article
30 Sep 2023
FDA Releases Draft Labeling Guidance For Biosimilar Products
Article
29 Sep 2023
Is It Biosimilar Or Interchangeable? It Won't Be Easy To Tell Under FDA's Latest Draft Labeling Guidance
Article
21 Aug 2023
Sarepta And Catalent File Answers In REGENXBIO v. Sarepta Litigation
Article
18 Jul 2023
Post-Trial Briefing In Regeneron V. Mylan Aflibercept BPCIA Case